Literature DB >> 17951196

Expression of p63 in cutaneous metastases.

Jean Kanitakis1, Brigitte Chouvet.   

Abstract

p63 is an oncogene belonging to the p53 gene family. In normal human skin, p63 is expressed by the least-differentiated keratinocytes of the epidermis and its appendages, by myoepithelial cells of sweat glands, and by a wide variety of primary tumors arising therefrom. The expression of p63 by metastatic skin tumors has been more controversial. In this study, we assessed the usefulness of p63 detection in the differential diagnosis between primary and secondary (metastatic) skin tumors. The expression of p63 was studied in 45 cases of cutaneous metastases, mostly of known primary origin, and 94 benign and malignant epithelial primary skin tumors. p63 was expressed by 85 (89%) of 96 primary skin tumors and 5 (11%) of 45 cutaneous metastases. These results suggest that p63 may be a useful adjunct in the diagnosis of skin carcinomas; however, contrary to what has been previously claimed, expression of p63 does not rule out the metastatic origin of a cutaneous carcinoma.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17951196     DOI: 10.1309/BD3K8U7KD969Y07U

Source DB:  PubMed          Journal:  Am J Clin Pathol        ISSN: 0002-9173            Impact factor:   2.493


  6 in total

1.  Spatiotemporal Regulation of ΔNp63 by TGFβ-Regulated miRNAs Is Essential for Cancer Metastasis.

Authors:  Ngoc H B Bui; Marco Napoli; Andrew John Davis; Hussein A Abbas; Kimal Rajapakshe; Cristian Coarfa; Elsa R Flores
Journal:  Cancer Res       Date:  2020-04-20       Impact factor: 12.701

2.  Functional interplay between p63 and p53 controls RUNX1 function in the transition from proliferation to differentiation in human keratinocytes.

Authors:  I Masse; L Barbollat-Boutrand; M Molina; O Berthier-Vergnes; N Joly-Tonetti; M T Martin; C Caron de Fromentel; J Kanitakis; J Lamartine
Journal:  Cell Death Dis       Date:  2012-06-07       Impact factor: 8.469

Review 3.  p63 Is a Promising Marker in the Diagnosis of Unusual Skin Cancer.

Authors:  Artem Smirnov; Lucia Anemona; Flavia Novelli; Cristina M Piro; Margherita Annicchiarico-Petruzzelli; Gerry Melino; Eleonora Candi
Journal:  Int J Mol Sci       Date:  2019-11-17       Impact factor: 5.923

4.  p63 expression in human tumors and normal tissues: a tissue microarray study on 10,200 tumors.

Authors:  Stefan Steurer; Claudia Riemann; Franziska Büscheck; Andreas M Luebke; Martina Kluth; Claudia Hube-Magg; Andrea Hinsch; Doris Höflmayer; Sören Weidemann; Christoph Fraune; Katharina Möller; Anne Menz; Margit Fisch; Michael Rink; Christian Bernreuther; Patrick Lebok; Till S Clauditz; Guido Sauter; Ria Uhlig; Waldemar Wilczak; David Dum; Ronald Simon; Sarah Minner; Eike Burandt; Rainer Krech; Till Krech; Andreas H Marx
Journal:  Biomark Res       Date:  2021-01-25

5.  Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immunotherapy for the treatment of nonmelanoma skin cancer.

Authors:  Ann W Silk; Christopher A Barker; Shailender Bhatia; Kathryn B Bollin; Sunandana Chandra; Zeynep Eroglu; Brian R Gastman; Kari L Kendra; Harriet Kluger; Evan J Lipson; Kathleen Madden; David M Miller; Paul Nghiem; Anna C Pavlick; Igor Puzanov; Guilherme Rabinowits; Emily S Ruiz; Vernon K Sondak; Edward A Tavss; Michael T Tetzlaff; Isaac Brownell
Journal:  J Immunother Cancer       Date:  2022-07       Impact factor: 12.469

6.  Primary Mucinous Adenocarcinoma of the Upper Eyelid in an African American Female: A Rare Clinical Entity. A Case Report and Literature Review.

Authors:  Prashanth Ashok Kumar; Shweta Paulraj; Seung S Hahn; Abirami Sivapiragasam
Journal:  Cureus       Date:  2019-11-28
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.